MicroRNA (miRNA) genes encode an abundant class of ~22-nucleotide small RNAs that are thought to control gene expression at the post-transcriptional levels. Although the importance of miRNA-mediated gene regulation is now evident, as miRNA genes were shown to play diverse functional roles in animals, their mechanisms of action remain elusive. We have recently found that miRNA genes encoding identical mature miRNAs could have distinct biological activities that are determined by their cognate pre-miRNA loops, revealing unexpected regulatory complexity encoded in the pre-miRNA loops. These findings prompted us to reexamine some of the fundamental assumptions in the miRNA field. It was noted in the original discovery of the C. elegans lin-4 gene that mutations and deletions in lin-4 genes invariably affect including the primary (pri), precursor (pre), and mature miRNA species, which all contain sequences complementary to cognate target genes. Thus, phenotypes observed for loss of miRNA genes in worms and mice cannot be attributed to mature miRNA specie alone. Together, the limitations of current assumption and our surprising discovery of pre-miRNA loop function suggest that pri- and pre-miRNA species may play direct roles in target gene regulation. Here we propose to examine the mechanisms by which pre-miRNA loops control activity of miRNA genes using biochemical and genetic approaches. We will further dissect the structure and sequence elements beyond mature miRNA regions that are important for the activity of miRNA genes (aim 1), identify the protein and RNA components that contribute to the pre-miRNA loop functions (aim 2), and delineate the roles of premiRNA loop nucleotides in target gene recognition (aim 3). The proposed study will shed fundamental insights into gene regulation by miRNA genes and yield novel principles for target gene prediction and for designing more efficient gene silencing molecules targeting messenger RNAs and miRNA genes.

National Institute of Health (NIH)
National Cancer Institute (NCI)
NIH Director’s Pioneer Award (NDPA) (DP1)
Project #
Application #
Study Section
Special Emphasis Panel (ZGM1-NDPA-B (02))
Program Officer
Mietz, Judy
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Achelois Pharmaceuticals, Inc.
San Francisco
United States
Zip Code
Schaffert, Steven A; Loh, Christina; Wang, Song et al. (2015) mir-181a-1/b-1 Modulates Tolerance through Opposing Activities in Selection and Peripheral T Cell Function. J Immunol 195:1470-9
Li, Xingnan; Nadauld, Lincoln; Ootani, Akifumi et al. (2014) Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture. Nat Med 20:769-77
Zheng, Qiupeng; Cai, Xiaohong; Tan, Meng How et al. (2014) Precise gene deletion and replacement using the CRISPR/Cas9 system in human cells. Biotechniques 57:115-24
Chen, Chang-Zheng; Schaffert, Steven; Fragoso, Rita et al. (2013) Regulation of immune responses and tolerance: the microRNA perspective. Immunol Rev 253:112-28
Chen, Chang-Zheng (2013) An unsolved mystery: the target-recognizing RNA species of microRNA genes. Biochimie 95:1663-76
Fragoso, Rita; Mao, Tin; Wang, Song et al. (2012) Modulating the strength and threshold of NOTCH oncogenic signals by mir-181a-1/b-1. PLoS Genet 8:e1002855
Kluiver, J L; Chen, C-Z (2012) MicroRNAs regulate B-cell receptor signaling-induced apoptosis. Genes Immun 13:239-44
Arnold, Christopher P; Tan, Ruoying; Zhou, Baiyu et al. (2011) MicroRNA programs in normal and aberrant stem and progenitor cells. Genome Res 21:798-810
Yue, Si-Biao; Trujillo, Robin Deis; Tang, Yujie et al. (2011) Loop nucleotides control primary and mature miRNA function in target recognition and repression. RNA Biol 8:1115-23